"Gain a Better Understanding of Effective Methods for Identifying Foreign Particulate."
Foreign particulate analysis is a critical aspect of pharmaceutical manufacturing and nonconformance investigations. The approaches and methodologies for analyzing foreign particulate vary depending on whether it is a single particle or a population of particles, as well as the physical properties of the particles themselves.
Case Studies in Foreign Particulate Analysis will present an overview of manual and automated methodologies for characterizing foreign particulate matter in pharmaceutical investigations and cleanliness studies. Several examples will be presented showing the various approaches to particulate identification.
During this webinar we will discuss both manual types of analysis (including SEM-EDS, microscopy, FTIR, and Raman), and automated types of analysis (including automated SEM (CCSEM) and automated Raman (SPE/LIBS). In addition, several case studies will be presented as examples of the utility of both types of analyses.
Gateway Webinar: Strategies for Biowaiver Application for Generic Nasal Spray...BCNorris Consulting
The active pharmaceutical ingredient (API) size distribution within the final formulation of a drug product is critical as it relates to bioavailability, rates of absorption, and stability of that drug product. Gaining an understanding of the API particle size distribution (PSD) is becoming of greater importance to regulatory agencies, particularly as they relate to the Critical Path Opportunity and biowaiver applications. In fact, a successful ANDA application for mometasone furoate nasal spray utilized Raman spectroscopy as an in vitro study technology in lieu of repeating a clinical endpoint study.
In this webinar, Gateway Analytical will highlight techniques using Raman spectroscopy for abbreviated new drug applications (ANDA) with FDA. Next Breath will present an overview of in vitro bioequivalence requirements and approaches incorporating this new technique.
Analysis using automated Raman technology that combines optical microscopy and Raman spectroscopy will be described. Interpretation of single and agglomerated particles sizes will be presented. In addition, the pros and cons of various instrument approaches will be highlighted. The webinar will conclude with an overview of Gateway’s and Next Breath’s combined strategy for establishing in vitro bioequivalence for regulatory submissions.
DCN Diagnostics. Design and Development of Lateral Flow Assay SystemsBrendan O'Farrell
DCN Diagnostics designs and develops rapid assay systems for medical and veterinary diagnostics, bio-defense, agriculture, environmental testing and other market segments. DCN's service offering includes contract assay development, education and training courses in lateral flow technologies, industrial design and mechanical engineering services related to development of related devices for rapid diagnostics. Our specialties include lateral flow, flow through and microfluidic assay formats, and we have developed qualitative, quantitative, visual or fluorescent assay systems. DCN's ISO 9001:228 and EN 13485 compliant quality system is set up to allow us to deliver the full FDA compliant design history file. Our process and unique teams of highly experienced development scientists working alongside our engineering teams allow us to deliver the product, not just the parts. DCN Diagnostics is the sole supplier of cellulose nanobead technology for lateral flow diagnostics outside of Japan and can supply technical consulting and development assistance to companies wishing to develop and manufacture highly sensitive and quantitative lateral flow assays using the NanoAct (tm) beads. Our experience in multiplexing and joint ownership in the Symbolics patents covering aspects of multipex arraying in lateral flow formats allows DCN to assist our clients in creating highly unique and functional assays for any environment or application. DCN also provides our unique UltraGold (tm) colloidal gold for use in lateral flow assays. DCN's 40nm gold colloid is highly controlled, very stable and designed specifically for use in lateral flow and flow through assays.
The need for metals cleanliness in the automotive industry has increased in the last decade. As technology continues to evolve, automotive part suppliers are increasingly being compelled to follow more stringent fluid system purity standards. Metals cleanliness is an important component to meeting these standards.
Analyzing automotive parts for cleanliness aids parts manufacturers in monitoring and/or isolating any contamination, including abrasive materials. Manufacturers who experience abrasive material contamination in fluids have experienced significant revenue losses due to production stoppages, increased failure rates, recalls and warranty costs. These types of situations are making metals cleanliness testing a high priority for parts manufacturers and the automotive industry as a whole.
Automated scanning electron microscopy (SEM) is an essential technique for analyzing possible contamination. Automated SEM provides individual particle size, shape and composition, along with a particle size distribution as a whole, for inorganic and metallic particles. Customized reports that follow ISO 16232 guidelines are also provided to help determine the next steps for the automotive part suppliers seeking to remediate contamination issues.
Participants of this webinar will learn what the definition of metals cleanliness, the technique of automated scanning electron microscopy, how SEM is used to analyze and monitor metals cleanliness and how the resulting data is useful to the automotive industry.
Lateral flow assays are the most robust, mature immuno sensor available today. Performance in some applications has historically been limited by difficulties in multiplexing and quantification. Novel approaches have been developed and commercialized in recent years that allow for the development and manufacturing of highly multiplexed arrays in lateral flow assays. The patented Symbolics (tm) approach is one such methodology. Symboics (tm) allows for the creation of arrays in lateral flow fields that develop evenly, allowing in turn for the creation of highly complex features such as letters and symbols and also allows for creation of multiplex assays with advanced features such as internal controls. This presentation introduces the principles of multiplexed arraying and the Symbolics technology
Presentation regarding the standards Independent Electronic Component Distributors should utilize to mitigate risk and financial exposure of there primes and subs.
Gateway Webinar: Strategies for Biowaiver Application for Generic Nasal Spray...BCNorris Consulting
The active pharmaceutical ingredient (API) size distribution within the final formulation of a drug product is critical as it relates to bioavailability, rates of absorption, and stability of that drug product. Gaining an understanding of the API particle size distribution (PSD) is becoming of greater importance to regulatory agencies, particularly as they relate to the Critical Path Opportunity and biowaiver applications. In fact, a successful ANDA application for mometasone furoate nasal spray utilized Raman spectroscopy as an in vitro study technology in lieu of repeating a clinical endpoint study.
In this webinar, Gateway Analytical will highlight techniques using Raman spectroscopy for abbreviated new drug applications (ANDA) with FDA. Next Breath will present an overview of in vitro bioequivalence requirements and approaches incorporating this new technique.
Analysis using automated Raman technology that combines optical microscopy and Raman spectroscopy will be described. Interpretation of single and agglomerated particles sizes will be presented. In addition, the pros and cons of various instrument approaches will be highlighted. The webinar will conclude with an overview of Gateway’s and Next Breath’s combined strategy for establishing in vitro bioequivalence for regulatory submissions.
DCN Diagnostics. Design and Development of Lateral Flow Assay SystemsBrendan O'Farrell
DCN Diagnostics designs and develops rapid assay systems for medical and veterinary diagnostics, bio-defense, agriculture, environmental testing and other market segments. DCN's service offering includes contract assay development, education and training courses in lateral flow technologies, industrial design and mechanical engineering services related to development of related devices for rapid diagnostics. Our specialties include lateral flow, flow through and microfluidic assay formats, and we have developed qualitative, quantitative, visual or fluorescent assay systems. DCN's ISO 9001:228 and EN 13485 compliant quality system is set up to allow us to deliver the full FDA compliant design history file. Our process and unique teams of highly experienced development scientists working alongside our engineering teams allow us to deliver the product, not just the parts. DCN Diagnostics is the sole supplier of cellulose nanobead technology for lateral flow diagnostics outside of Japan and can supply technical consulting and development assistance to companies wishing to develop and manufacture highly sensitive and quantitative lateral flow assays using the NanoAct (tm) beads. Our experience in multiplexing and joint ownership in the Symbolics patents covering aspects of multipex arraying in lateral flow formats allows DCN to assist our clients in creating highly unique and functional assays for any environment or application. DCN also provides our unique UltraGold (tm) colloidal gold for use in lateral flow assays. DCN's 40nm gold colloid is highly controlled, very stable and designed specifically for use in lateral flow and flow through assays.
The need for metals cleanliness in the automotive industry has increased in the last decade. As technology continues to evolve, automotive part suppliers are increasingly being compelled to follow more stringent fluid system purity standards. Metals cleanliness is an important component to meeting these standards.
Analyzing automotive parts for cleanliness aids parts manufacturers in monitoring and/or isolating any contamination, including abrasive materials. Manufacturers who experience abrasive material contamination in fluids have experienced significant revenue losses due to production stoppages, increased failure rates, recalls and warranty costs. These types of situations are making metals cleanliness testing a high priority for parts manufacturers and the automotive industry as a whole.
Automated scanning electron microscopy (SEM) is an essential technique for analyzing possible contamination. Automated SEM provides individual particle size, shape and composition, along with a particle size distribution as a whole, for inorganic and metallic particles. Customized reports that follow ISO 16232 guidelines are also provided to help determine the next steps for the automotive part suppliers seeking to remediate contamination issues.
Participants of this webinar will learn what the definition of metals cleanliness, the technique of automated scanning electron microscopy, how SEM is used to analyze and monitor metals cleanliness and how the resulting data is useful to the automotive industry.
Lateral flow assays are the most robust, mature immuno sensor available today. Performance in some applications has historically been limited by difficulties in multiplexing and quantification. Novel approaches have been developed and commercialized in recent years that allow for the development and manufacturing of highly multiplexed arrays in lateral flow assays. The patented Symbolics (tm) approach is one such methodology. Symboics (tm) allows for the creation of arrays in lateral flow fields that develop evenly, allowing in turn for the creation of highly complex features such as letters and symbols and also allows for creation of multiplex assays with advanced features such as internal controls. This presentation introduces the principles of multiplexed arraying and the Symbolics technology
Presentation regarding the standards Independent Electronic Component Distributors should utilize to mitigate risk and financial exposure of there primes and subs.
Design and development of lateral flow assays for field useBrendan O'Farrell
Lateral flow assays are the most mature, stable, field deployable sensor available today. They can be used in myriad applications, from medical diagnostics to veterinary testing, agriculture, bio-defense, food testing and environmental testing, to name a few. Performance of these assays has evolved to the point where they can equal that of much more highly complex laboratory based diagnostic test formats. They can be quantitative, multiplexed and highly sensitive if developed and manufactured correctly. Design and development of these high performance lateral flow systems requires a from-first-principles approach, with an eye to optimizing the system for reproduciblity and sensitivity. Employing user - centered design and development practices greatly improves the odds of successful commercialization. DCN Diagnostics (formerly Diagnostic Consulting Network) develops high performance lateral flow assay systems for use in any environment. Our concurrent design and development process, employing cross functional teams of industrial design and mechanical engineers alongside our immunoassay development teams, ensures that the right product is developed the right way to allow for most efficient regulatory approval and commercialization. Our development process is fully design controlled and operates under our ISO 9001:2008 and EN 13485 compliant quality system. With literally hundreds of assays developed, and transferred to manufacturing, DCN is the go-to supplier of contract development services in the point of care diagnostic test market. Additionally, our consulting teams can provide a deep strategic vision to our clients, assisting in all aspects of product development and commercialization, including regulatory affairs and clinical trial management. This presentation describes DCN's development process and illustrates the benefit of a user centered design process in creating the right rapid assay for your market, focusing on field deployed tests for clinical diagnostics, veterinary testing and bio-defense applications. A variety of case studies are shown, illustrating the principles discussed.
FDA Feedback Regarding Chemistry for Toxicological Risk Assessment – How to M...Greenlight Guru
One of the newest biocompatibility evaluation tools is extractable and leachable (E&L) testing. A correctly run E&L study, with an accompanying toxicological evaluation, can be used to replace traditional tests like systemic toxicity, genotoxicity, reproductive toxicity, and carcinogenicity. The data gained from these studies can help understand the total risk of your device to an intended population of users; but unlike the traditional animal tests, it comes with separate risks. These tests are not your typical “stamped” tests, where every lab gives a similar quality of results. Because of this, FDA has refined a strict, detailed, list of parameters that should be included in every test. This list is very dynamic and is changing rapidly; the best way to make sure you are performing the correct version of the test is to learn from the most recent FDA feedback on studies.
TAKEAWAY ITEMS:
• Understand recent FDA feedback and dissect what FDA is asking/looking for
• Learn how to address these concerns and develop a protocol to make sure you don’t receive similar questions
• Recognize how FDA is using the new ISO 10993-18 and where they deviate from that standard
This session took place live at the Greenlight Guru True Quality Virtual Summit, a three-day event for medical device professionals to learn to get their devices to market faster, stay ahead of regulatory changes, and use quality as their multiplier to grow their device business.
Random number generators are a critical component of security systems. They also find use in a variety of other applications from lotteries to scientific simulations. Randomness tests seek to find whether a generator exhibits any signs of non-random behaviour. However, many statistical test batteries are unable to reliably detect certain issues present in poor generators. Severe mistakes when determining whether a given generator passes the tests are common. Irregularities in sample size selection and a lack of granularity in test result interpretation contribute to this. This work provides evidence of these and other issues in several statistical test batteries. We identify problems with current practices and recommend improvements. The novel concept of suitable randomness is presented, precisely defining two bias bounds for a TRNG, instead of a simple binary pass/fail outcome. Randomness naivety is also introduced, outlining how binary pass/fail analysis cannot express the complexities of RNG output in a manner that is useful to determine whether a generator is suitable for a given range of applications.
This is one slide set in a multi part series on the BGA rework process. In this section the BGA cleaning and inspection process is explained. Get more information on www.solder.net or to see or multitude of soldering process videos.
This is a summary of the newest PCB cleanliness and residue measuring requirements as part of the IPC J-STD-001H. More on this standard including training at solder.net
Introduction to NDT and Visual Inspection Hareesh K
This presentation will gives you basic idea about Non destructive testing and brief detail about Visual Inspection Technique.This topic is included in UG level Mechanical Engineering Syllabus by all top Indian Universities
International Refereed Journal of Engineering and Science (IRJES) is a peer reviewed online journal for professionals and researchers in the field of computer science. The main aim is to resolve emerging and outstanding problems revealed by recent social and technological change. IJRES provides the platform for the researchers to present and evaluate their work from both theoretical and technical aspects and to share their views.
www.irjes.com
Design and development of lateral flow assays for field useBrendan O'Farrell
Lateral flow assays are the most mature, stable, field deployable sensor available today. They can be used in myriad applications, from medical diagnostics to veterinary testing, agriculture, bio-defense, food testing and environmental testing, to name a few. Performance of these assays has evolved to the point where they can equal that of much more highly complex laboratory based diagnostic test formats. They can be quantitative, multiplexed and highly sensitive if developed and manufactured correctly. Design and development of these high performance lateral flow systems requires a from-first-principles approach, with an eye to optimizing the system for reproduciblity and sensitivity. Employing user - centered design and development practices greatly improves the odds of successful commercialization. DCN Diagnostics (formerly Diagnostic Consulting Network) develops high performance lateral flow assay systems for use in any environment. Our concurrent design and development process, employing cross functional teams of industrial design and mechanical engineers alongside our immunoassay development teams, ensures that the right product is developed the right way to allow for most efficient regulatory approval and commercialization. Our development process is fully design controlled and operates under our ISO 9001:2008 and EN 13485 compliant quality system. With literally hundreds of assays developed, and transferred to manufacturing, DCN is the go-to supplier of contract development services in the point of care diagnostic test market. Additionally, our consulting teams can provide a deep strategic vision to our clients, assisting in all aspects of product development and commercialization, including regulatory affairs and clinical trial management. This presentation describes DCN's development process and illustrates the benefit of a user centered design process in creating the right rapid assay for your market, focusing on field deployed tests for clinical diagnostics, veterinary testing and bio-defense applications. A variety of case studies are shown, illustrating the principles discussed.
FDA Feedback Regarding Chemistry for Toxicological Risk Assessment – How to M...Greenlight Guru
One of the newest biocompatibility evaluation tools is extractable and leachable (E&L) testing. A correctly run E&L study, with an accompanying toxicological evaluation, can be used to replace traditional tests like systemic toxicity, genotoxicity, reproductive toxicity, and carcinogenicity. The data gained from these studies can help understand the total risk of your device to an intended population of users; but unlike the traditional animal tests, it comes with separate risks. These tests are not your typical “stamped” tests, where every lab gives a similar quality of results. Because of this, FDA has refined a strict, detailed, list of parameters that should be included in every test. This list is very dynamic and is changing rapidly; the best way to make sure you are performing the correct version of the test is to learn from the most recent FDA feedback on studies.
TAKEAWAY ITEMS:
• Understand recent FDA feedback and dissect what FDA is asking/looking for
• Learn how to address these concerns and develop a protocol to make sure you don’t receive similar questions
• Recognize how FDA is using the new ISO 10993-18 and where they deviate from that standard
This session took place live at the Greenlight Guru True Quality Virtual Summit, a three-day event for medical device professionals to learn to get their devices to market faster, stay ahead of regulatory changes, and use quality as their multiplier to grow their device business.
Random number generators are a critical component of security systems. They also find use in a variety of other applications from lotteries to scientific simulations. Randomness tests seek to find whether a generator exhibits any signs of non-random behaviour. However, many statistical test batteries are unable to reliably detect certain issues present in poor generators. Severe mistakes when determining whether a given generator passes the tests are common. Irregularities in sample size selection and a lack of granularity in test result interpretation contribute to this. This work provides evidence of these and other issues in several statistical test batteries. We identify problems with current practices and recommend improvements. The novel concept of suitable randomness is presented, precisely defining two bias bounds for a TRNG, instead of a simple binary pass/fail outcome. Randomness naivety is also introduced, outlining how binary pass/fail analysis cannot express the complexities of RNG output in a manner that is useful to determine whether a generator is suitable for a given range of applications.
This is one slide set in a multi part series on the BGA rework process. In this section the BGA cleaning and inspection process is explained. Get more information on www.solder.net or to see or multitude of soldering process videos.
This is a summary of the newest PCB cleanliness and residue measuring requirements as part of the IPC J-STD-001H. More on this standard including training at solder.net
Introduction to NDT and Visual Inspection Hareesh K
This presentation will gives you basic idea about Non destructive testing and brief detail about Visual Inspection Technique.This topic is included in UG level Mechanical Engineering Syllabus by all top Indian Universities
International Refereed Journal of Engineering and Science (IRJES) is a peer reviewed online journal for professionals and researchers in the field of computer science. The main aim is to resolve emerging and outstanding problems revealed by recent social and technological change. IJRES provides the platform for the researchers to present and evaluate their work from both theoretical and technical aspects and to share their views.
www.irjes.com
Micro-XRF EDS can be used in a complementary manner with SEM/EDS to obtain semi-quantitative compositional analysis for identification of alloy types at elemental concentrations above 100 ppm (0.01 wt%). A presentation by Element Materials Technology expert Dan DeMiglio.
This presentation summarizes a framework for considering intrinsic and extrinsic factors that may contribute to the propensity for glass vials to undergo delamination.
Proactive vs Reactive Glass Delamination Testing in PharmaceuticalsBCNorris Consulting
Join Gateway Analytical Scientists as they discuss UPS <1660> recommendations and Gateway’s approach to different types of glass delamination investigations.
Glass as a packaging material in pharmaceutical packagingShweta Shelke
This presentation gives a brief idea about the types of glasses used in pharmaceutical industry and its intended use. Different tests used for assuring its quality for intended use.
Quantitative methylene blue staining of pharmaceutical glass vialsmatthewmicahhall
This presentation provides a summary of recent work by my research group on the use of methylene blue staining as a method for characterizing pharmaceutical glass vials.
Foreign particulate in drug products originate from a variety of sources. Such sources can include machinery used in drug manufacturing, drug packaging components, cleaning utensils and products, personnel wearing personal protective equipment (PPE) and laboratory surfaces. Typical contaminants include polymers, fibers, burnt material and metallic particulate.
Hair is a significant type of contamination seen in pharmaceutical products. The biological nature of hair can generate many types of concerns when this contaminant is found in drug products. Identification of hair as a contaminant and narrowing down possible sources of contamination can aid in determining the impact on product. It can also provide valuable information to remediate the problem in the future.
Microscopy is a valuable tool in the analysis process, enabling a scientist to accurately determine if a contaminant is a hair. Microscopy also provides additional relevant information, such as hair type (i.e. human, animal or textile in nature) that can lead to the source of the contamination.
Exploratory testing Kari Kakkonen KDS2015Kari Kakkonen
My presentation about Exploratory Testing in Knowit Developer Summit 2015 in Stockholm, describing some basics for this effective way to test. I mention a few tools, and demoed some.
Exploratory Testing Kari Kakkonen BTD 2017Kari Kakkonen
My talk on Exploratory Testing basics and its future at Belgium Testing Days / BNTQB Test Summit 2017 https://btdconf.org/ bit of slides revamp included
Exploratory Testing Basics and Future Kari Kakkonen Moscow 2018Kari Kakkonen
My slides at #TestConMoscow 2018 about Exploratory Testing basics, experiences and future. I go through some basic on concepts of exploratory testing, discuss where and why exploratory testing typically fits, and what is in store for exploratory testing in future - mixing it with use of tools and soon even AI as a helper.
My presentation on Exploratory Testing at CzechTest in Prague on June 25, 2015. Experiences and some material from our Knowit course with the same title.
Remote usability testing and remote user research for usabilityUser Vision
From User Vision's presentation on remote usability testing describing some of the main methods, challenges, tools and tips for successful remote usability testing for user experience
My talk at #TestConVilnius 19.10.2017 about what is exploratory testing (ET), how can you make it work and what is there in the future of exploratory testing: test management tool support, testing with tools, AI support, ET as standard way of testing in especially agile and DevOps projects
Controlling Project during Development with a Defect Model, Ben Linders, Euro...Ben Linders
To get more insight into the quality of the product during development, it is needed to measure processes with two views: Introduction of defects, and detection. Introduction is done during the requirements, architecture, design and coding phases; defects are either introduced into documents or into the actual product code. Detection is done in test phases, and in the previously mentioned phases by means of inspections and reviews. By using these two measurements, a project can determine if and what the quality risk is: Too many defects in the product, or insufficient testing done.
The presentation will focus upon:
- Goals: What was the purpose of the model, why was it developed, what did we want to reach?
- How: Both the definition of the model and its implementation and application will be highlighted?
- Tools: The tool that was developed to implement the model, how it works, strengths.
- Results: How did the model and tool help the project? Did it live up to its purpose?
- Success factors: What were the key issues that we have dealt successfully with? Why did we focus on them, and how?
- Future: How is this model used in future projects, what could further increase its benefits?
The presentation will show the benefits that the model/tool has brought to the project and organisation. Mainly it was the ability to manage process & product quality, and support decisions, based on data collected in the project and industrial date, i.e. without having to build up historical data in previous projects.
The defect model uses techniques like Orthogonal Defect Classification and Test Matrices for analysis of the defect data. Feedback of the data towards designers, testers, and project management was key in validating the data, and getting good analysis results for corrective and preventive actions.
A tale of scale & speed: How the US Navy is enabling software delivery from l...sonjaschweigert1
Rapid and secure feature delivery is a goal across every application team and every branch of the DoD. The Navy’s DevSecOps platform, Party Barge, has achieved:
- Reduction in onboarding time from 5 weeks to 1 day
- Improved developer experience and productivity through actionable findings and reduction of false positives
- Maintenance of superior security standards and inherent policy enforcement with Authorization to Operate (ATO)
Development teams can ship efficiently and ensure applications are cyber ready for Navy Authorizing Officials (AOs). In this webinar, Sigma Defense and Anchore will give attendees a look behind the scenes and demo secure pipeline automation and security artifacts that speed up application ATO and time to production.
We will cover:
- How to remove silos in DevSecOps
- How to build efficient development pipeline roles and component templates
- How to deliver security artifacts that matter for ATO’s (SBOMs, vulnerability reports, and policy evidence)
- How to streamline operations with automated policy checks on container images
Communications Mining Series - Zero to Hero - Session 1DianaGray10
This session provides introduction to UiPath Communication Mining, importance and platform overview. You will acquire a good understand of the phases in Communication Mining as we go over the platform with you. Topics covered:
• Communication Mining Overview
• Why is it important?
• How can it help today’s business and the benefits
• Phases in Communication Mining
• Demo on Platform overview
• Q/A
Threats to mobile devices are more prevalent and increasing in scope and complexity. Users of mobile devices desire to take full advantage of the features
available on those devices, but many of the features provide convenience and capability but sacrifice security. This best practices guide outlines steps the users can take to better protect personal devices and information.
Goodbye Windows 11: Make Way for Nitrux Linux 3.5.0!SOFTTECHHUB
As the digital landscape continually evolves, operating systems play a critical role in shaping user experiences and productivity. The launch of Nitrux Linux 3.5.0 marks a significant milestone, offering a robust alternative to traditional systems such as Windows 11. This article delves into the essence of Nitrux Linux 3.5.0, exploring its unique features, advantages, and how it stands as a compelling choice for both casual users and tech enthusiasts.
Observability Concepts EVERY Developer Should Know -- DeveloperWeek Europe.pdfPaige Cruz
Monitoring and observability aren’t traditionally found in software curriculums and many of us cobble this knowledge together from whatever vendor or ecosystem we were first introduced to and whatever is a part of your current company’s observability stack.
While the dev and ops silo continues to crumble….many organizations still relegate monitoring & observability as the purview of ops, infra and SRE teams. This is a mistake - achieving a highly observable system requires collaboration up and down the stack.
I, a former op, would like to extend an invitation to all application developers to join the observability party will share these foundational concepts to build on:
Essentials of Automations: The Art of Triggers and Actions in FMESafe Software
In this second installment of our Essentials of Automations webinar series, we’ll explore the landscape of triggers and actions, guiding you through the nuances of authoring and adapting workspaces for seamless automations. Gain an understanding of the full spectrum of triggers and actions available in FME, empowering you to enhance your workspaces for efficient automation.
We’ll kick things off by showcasing the most commonly used event-based triggers, introducing you to various automation workflows like manual triggers, schedules, directory watchers, and more. Plus, see how these elements play out in real scenarios.
Whether you’re tweaking your current setup or building from the ground up, this session will arm you with the tools and insights needed to transform your FME usage into a powerhouse of productivity. Join us to discover effective strategies that simplify complex processes, enhancing your productivity and transforming your data management practices with FME. Let’s turn complexity into clarity and make your workspaces work wonders!
The Art of the Pitch: WordPress Relationships and SalesLaura Byrne
Clients don’t know what they don’t know. What web solutions are right for them? How does WordPress come into the picture? How do you make sure you understand scope and timeline? What do you do if sometime changes?
All these questions and more will be explored as we talk about matching clients’ needs with what your agency offers without pulling teeth or pulling your hair out. Practical tips, and strategies for successful relationship building that leads to closing the deal.
GraphSummit Singapore | The Art of the Possible with Graph - Q2 2024Neo4j
Neha Bajwa, Vice President of Product Marketing, Neo4j
Join us as we explore breakthrough innovations enabled by interconnected data and AI. Discover firsthand how organizations use relationships in data to uncover contextual insights and solve our most pressing challenges – from optimizing supply chains, detecting fraud, and improving customer experiences to accelerating drug discoveries.
Generative AI Deep Dive: Advancing from Proof of Concept to ProductionAggregage
Join Maher Hanafi, VP of Engineering at Betterworks, in this new session where he'll share a practical framework to transform Gen AI prototypes into impactful products! He'll delve into the complexities of data collection and management, model selection and optimization, and ensuring security, scalability, and responsible use.
Unlocking Productivity: Leveraging the Potential of Copilot in Microsoft 365, a presentation by Christoforos Vlachos, Senior Solutions Manager – Modern Workplace, Uni Systems
UiPath Test Automation using UiPath Test Suite series, part 5DianaGray10
Welcome to UiPath Test Automation using UiPath Test Suite series part 5. In this session, we will cover CI/CD with devops.
Topics covered:
CI/CD with in UiPath
End-to-end overview of CI/CD pipeline with Azure devops
Speaker:
Lyndsey Byblow, Test Suite Sales Engineer @ UiPath, Inc.
UiPath Test Automation using UiPath Test Suite series, part 6DianaGray10
Welcome to UiPath Test Automation using UiPath Test Suite series part 6. In this session, we will cover Test Automation with generative AI and Open AI.
UiPath Test Automation with generative AI and Open AI webinar offers an in-depth exploration of leveraging cutting-edge technologies for test automation within the UiPath platform. Attendees will delve into the integration of generative AI, a test automation solution, with Open AI advanced natural language processing capabilities.
Throughout the session, participants will discover how this synergy empowers testers to automate repetitive tasks, enhance testing accuracy, and expedite the software testing life cycle. Topics covered include the seamless integration process, practical use cases, and the benefits of harnessing AI-driven automation for UiPath testing initiatives. By attending this webinar, testers, and automation professionals can gain valuable insights into harnessing the power of AI to optimize their test automation workflows within the UiPath ecosystem, ultimately driving efficiency and quality in software development processes.
What will you get from this session?
1. Insights into integrating generative AI.
2. Understanding how this integration enhances test automation within the UiPath platform
3. Practical demonstrations
4. Exploration of real-world use cases illustrating the benefits of AI-driven test automation for UiPath
Topics covered:
What is generative AI
Test Automation with generative AI and Open AI.
UiPath integration with generative AI
Speaker:
Deepak Rai, Automation Practice Lead, Boundaryless Group and UiPath MVP
Encryption in Microsoft 365 - ExpertsLive Netherlands 2024Albert Hoitingh
In this session I delve into the encryption technology used in Microsoft 365 and Microsoft Purview. Including the concepts of Customer Key and Double Key Encryption.
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...James Anderson
Effective Application Security in Software Delivery lifecycle using Deployment Firewall and DBOM
The modern software delivery process (or the CI/CD process) includes many tools, distributed teams, open-source code, and cloud platforms. Constant focus on speed to release software to market, along with the traditional slow and manual security checks has caused gaps in continuous security as an important piece in the software supply chain. Today organizations feel more susceptible to external and internal cyber threats due to the vast attack surface in their applications supply chain and the lack of end-to-end governance and risk management.
The software team must secure its software delivery process to avoid vulnerability and security breaches. This needs to be achieved with existing tool chains and without extensive rework of the delivery processes. This talk will present strategies and techniques for providing visibility into the true risk of the existing vulnerabilities, preventing the introduction of security issues in the software, resolving vulnerabilities in production environments quickly, and capturing the deployment bill of materials (DBOM).
Speakers:
Bob Boule
Robert Boule is a technology enthusiast with PASSION for technology and making things work along with a knack for helping others understand how things work. He comes with around 20 years of solution engineering experience in application security, software continuous delivery, and SaaS platforms. He is known for his dynamic presentations in CI/CD and application security integrated in software delivery lifecycle.
Gopinath Rebala
Gopinath Rebala is the CTO of OpsMx, where he has overall responsibility for the machine learning and data processing architectures for Secure Software Delivery. Gopi also has a strong connection with our customers, leading design and architecture for strategic implementations. Gopi is a frequent speaker and well-known leader in continuous delivery and integrating security into software delivery.
3. @GatewayTweets
#gatewaywebinars
What You Will Receive via Email
after the Webinar
Link to the Webinar Replay
Link to the Presentation
Slides
A Digital E-Certificate of
Attendance
Q&A at the end of
the webinar
4. @GatewayTweets
#gatewaywebinars
About Gateway Analytical
Located in Gibsonia, Pennsylvania, USA
Particulate
Identification Services
Detailed Report
Characterizing and
Identifying particulate
Customer Support to
help identity the source
of contaminates.
cGMP-compliant | FDA Registered & Inspected | ISO 17025 & ISO 9001
5. @GatewayTweets
#gatewaywebinars
About Gateway Analytical
Located in Gibsonia, Pennsylvania, USA
Particulate happens, but that
shouldn't stop your progress.
Our focus is to remove the
hurdles involved with identifying
foreign particulate and guide our
customers to fast remediation.